Epidemiologic evidence on the relation between nutrition and prostate cancer is reviewed. Little is known about the etiology of prostate cancer, despite its prominence as the leading cancer among men in the United States. Rational mechanisms for dietary influences on prostate carcinogenesis, including effects on production or metabolism of androgenic hormones, have been proposed, but because few suitable animal models have been developed, the laboratory literature on diet and prostate cancer is sparse. Despite strong ecologic data and largely consistent case-control and cohort data on dietary fat and prostate cancer, the role of this nutrient remains unclear. Few studies, to date, have adjusted the results for caloric intake, and no particular fat component has been consistently implicated. A notable finding is a strong positive association with intake of animal products, especially red meats, but this in itself does not specifically implicate fat. Epidemiologic investigations on vitamin A and carotenoids are divided almost equally between studies showing postive and inverse associations. The evidence from these studies for a protective effect of fruits and vegetables on prostate cancer, unlike many other cancer sites, is not convincing. The data on other dietary components that have been examined with regard to prostate cancer etiology (cadmium, zinc, vitamins C and D, beverages, and legumes) are too incomplete at this time to draw any inferences as to their importance. The evidence for anthropometric associations with prostate cancer is weak. Whereas a clear association with obesity has not been shown, a positive relationship to muscle mass, though not yet established conclusively, further suggests the importance of androgens in this cancer.
Similar content being viewed by others
References
Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973–1991: Tables and Graphs. Bethesda, MD (USA): National Cancer Institute, 1994; NIH Pub. No. 942789.
American Cancer Society. Cancer Facts and Figures-1995, Atlanta, GA (USA): American Cancer Society, Inc., 1995: 30.
Parkin DM, Pisani P, Ferlay J. Estimates of the world-wide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594–606.
Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents. Vol. 6. Lyon, France: International Agency for Research on Cancer, 1992; IARC Sci Pub. No. 120.
Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostatic cancer: a case-control study in Hawaii, Am J Epidemiol 1988; 127: 999–12.
Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection. JNCI 1990; 82: 1624–8.
Guileyardo JM, Johnson WD, Welsh RA, Akazaki K, Correa P. Prevalence of latent prostate carcinoma in two U.S. populations. JNCI 1980; 65: 311–6.
Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982; 29: 611–6.
Kolonel LN, Hinds MW, Hankin JH. Cancer patterns among migrant and native-born Japanese in Hawaii in relation to smoking, drinking, and dietary habits. In: Gelboin HV, MacMahon B, Matsushima T, Sugimura T, Takayama S, Takebe H. eds. Genetics and Environmental Factors in Experimental and Human Cancer. Tokyo, Japan: Japan Scientific Society Press, 1980: 327–40.
Nomura AMY, Kolonel LN. Prostate cancer: a current perspective. Am J Epidemiol 1991; 13: 200–27.
Berg JW. Can nutrition explain the pattern of international epidemiology of hormone-dependent cancers? Cancer Res 1975; 35: 3345–950.
Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990; 17: 337–47.
Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 3: 739–44.
Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1982; 1: 47–69.
Whittemore AS, Wu AH, Kolonel LN, et al. Family history and prostate cancer risk in black, white and Asian men in the United States and Canada. Am J Epidemiol 1995; 141: 732–40.
Coetzee GA, Ross RK. Re: Prostate cancer and the androgen receptor. JNCI 1994; 86: 872–73.
Brawley OW, Ford LG, Thompson I, Perlman JA, Kramer BS. 5-α-reductase inhibition and prostate cancer prevention. Cancer Epidemiol Biomarkers Prev 1994; 3: 177–82.
Howell MA. Factor analysis of international cancer mortality data and per capita food consumption. Br J Cancer 1974; 29: 328–36.
Blair A, Fraumeni JFJr. Geographic patterns of prostate cancer in the United States. JNCI 1978; 61: 379–84.
Armstrong B, Doll R, Environmental factors and cancer incidence and mortality in differenct countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617–31.
Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumpton. Cancer 1986; 58: 2363–71.
Kolonel LN, Hankin JH, Lee J, Chu S, Nomura AN, Hinds MW. Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 1981; 44: 332–9.
Schuman LM, Mandel JS, Radke A, Seal U, Halberg F, Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, Minnesota case-control study, 1976–1979. In: Magnus K, ed. Trends in Cancer Incidence: Causes and Implications. Washington DC: Hemisphere Publishing Corp., 1982: 345–54.
Graham S, Haughey B, Marshall J, et al. Diet in the epidemiology of carcinoma of the prostate gland. JNCI 1983; 70: 687–92.
Heshmat MY, Kaul L, Kovi J, et al. Nutrition and prostate cancer: a case-control study. Prostate 1985; 6: 7–17.
Talamini R, La Vecchia C, Decarli A, Negri E, Franceshi S. Nutrition, social factors and prostatic cancer in a Northern Italian population. Br J Cancer 1986; 53: 817–21.
Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE. Case-control studies of prostate cancer in blacks and whites in Southern California. JNCI 1987; 78: 869–74.
Ohno Y, Yoshida O, Oishi K, Okada K, Yamabe H, Schroeder FH. Dietary beta-carotene and cancer of the prostate: a case-control study in Kyoto, Japan. Cancer Res 1988: 48: 1331–6.
Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk. Cancer 1989; 64: 605–12.
West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special reference to aggressive tumors. Cancer Causes Control 1991; 2: 85–94.
Walker ARP, Walker BF, Tsotetsi NG, Sebitso C, Siwedi D, Walker AJ. Case-control study of prostate cancer in black patients in Soweto, South Africa. Br J Cancer 1992; 65: 438–41.
Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S, Negri E. Diet and prostatic cancer; a case-control study in Northern Italy. Nutr Cancer 1992; 18: 277–86.
Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity and body size in blacks, whites and Asians in the US and Canada. JNCI 1995; 87: 652–61.
Rohan TE, Howe GR, Burch JD, Jain M. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes and Control 1995; 6: 145–54.
Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. NCI Monogr 1979; 53: 149–55.
Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984; 120: 244–50.
Severson RK, Nomura AMY, Grove JS, Stemmermann GN. A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989; 49: 1857–60.
Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989; 64: 598–604.
Hsing AW, McLaughlin JK, Schuman LM, et al. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran brotherhood cohort study. Cancer Res 1990; 50: 6836–40.
Giovannucci E, Rimm EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. JNCI 1993; 85: 1571–9.
Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994; 5: 276–82.
Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. JNCI 1994; 86: 281–6.
Sugimura T. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutation Res 1985; 150: 33–41.
Ross RK, Bernstein L, Lobo RA, et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992; 339: 887–9.
Hsing AW, Comstock GW. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev 1993; 2: 27–32.
de Jong FH, Oishi K, Hayes RB, et al. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. Cancer Res 1991; 51: 3445–50.
Hill P, Wynder EL, Garbaczewski L, Garnes H, Walker ARP. Diet and urinary steroids in black and white North American men and black South African men. Cancer Res 1979; 39: 5101–5.
Key TJ, Roe L, Thorogood M, Moore JW, Clark GMG, Wang DY. Testosterone, sex hormone-binding globulin, calculated free testosterone, and oestradiol in male vegans and omnivores. Br J Nutr 1990; 64: 111–9.
National Research Council, Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press, 1989.
Ip C, Birt DF, Rogers AE, Mettlin C, eds. Dietary Fat and Cancer. Progress in Clinical and Biological Research. Vol. 222. New York, NY (USA): Alan R. Liss, Inc., 1986.
Middleton B, Byers T, Marshall J, Graham S. Dietary vitamin A and cancer—a multisite case-control study. Nutr Cancer 1986; 8: 107–16.
Kolonel LN, Hankin JH, Yoshizawa CN, Vitamin A and prostate cancer in elderly men: enhancement of risk. Cancer Res 1987; 47: 2982–5.
Hayes RB, Bogdanovicz JFAT, Schroeder FH, et al. Serum retinol and prostate cancer. Cancer 1988; 62: 2021–6.
Le Marchand L, Hankin JH, Kolonel LN, Wilkens LR. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: A reevaluation of the effect of dietary beta-carotene. Am J Epidemiol 1991: 133: 215–9.
Beecher GR, US Department of Agriculture, Bethesda, MD, USA. Personal communication, 1991.
Hirayama T. A large scale cohort study on cancer risks by diet-with special reference to the risk reducing effects of green-yellow vegetable consumption. In: Hayashi Y, Nagao M, Sugimura T, et al, eds. Diet, Nutrition and Cancer. Tokyo, Japan: Japan Sci Soc Press, 1986: 41–53.
Paganini-Hill A, Chao A, Ross RK, Henderson BE. Vitamin A, beta-carotene and the risk of cancer: a prospective study. JNCI 1987; 79: 443–8.
Reichman ME, Hayes RB, Ziegler RG, et al. Serum vitamin A and subsequent development of prostate cancer in the First National Health and Nutrition Examination Survery Epidemiologic Follow-up Study. Cancer Res 1990; 50: 2311–5.
Knekt P, Aromaa A, Maatela J, et al. Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am J Epidemiol 1990; 132: 857–70.
Khachik F, Beecher GR, Lusby WR. Separation, identification, and quantification of the major carotenoids in extracts of apricots, peaches, cantaloupe, and pink grapefruit by liquid chromatography. J Agric Food Chem 1989; 37: 1465–73.
Hambidge KM, Casey CE, Krebs NF. Zinc. In: Mertz W, Underwood EJ, eds. Trace Elements in Human and Animal Nutrition. Vol. 2. 5th ed.. Orlando, FL (USA): Academic Press, Inc., 1986:1–137.
Feustel A, Wennrich R, Steiniger D, Klaus P. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol Res 1982; 10: 301–3.
Kolonel LN, Winkelstein W Jr. Cadmium and prostatic carcinoma. Lancet 1977; ii: 566–7.
Abd Elghany N, Schumacher MC, Slattery ML, West DW, Lee JS. Occupation, cadmium exposure, and prostate cancer. Epidemiology 1990; 1: 107–15.
Hiatt RA, Armstrong MA, Klatsky AL, Sidney S. Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control 1994; 5: 66–72.
Tavani A, Negri E, Franceschi S, Talamini R, La Vecchia C. Alcohol consumption and risk of prostate cancer. Nutr Cancer 1994; 21: 25–31.
Hirayama T. Life-style and cancer: from epidemiological evidence to public behavior change to mortality reduction of target cancers. NCI Monogr 1992; 12: 65–74.
Corder EH, Guess HA, Hulka BS, et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 1993; 2: 467–72.
Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites. Cancer Causes Control 1995; 6: 235–9.
Heilbrun LK, Nomura A, Stemmermann GN. Black tea consumption and cancer risk: a prospective study. Br J Cancer 1986; 54: 677–83.
Jacobsen BK, Bjelke E, Kvale G, Heuch I. Coffee drinking, mortality, and cancer incidence: Results from a Norwegian prospective study. JNCI 1986; 76: 823–31.
Wynder EL, Mabuchi K, Whitmore WFJr. Epidemiology of cancer of the prostate. Cancer 1971; 28: 344–60.
La Vecchia C, Negri E, Parazzini F, et al. Height and cancer risk in a network of case-control studies from northern Italy. Int J Cancer 1990; 45: 275–9.
Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chron Dis 1979; 32: 563–76.
Thompson MM, Garland C, Barrett-Connor E, Khaw K, Friedlander NJ, Wingard DL. Heart disease risk factors, diabetes and prostatic cancer in an adult community. Am J Epidemiol 1989; 129: 511–17.
Whittemore AS, Paffenbarger RSJr, Anderson K, Lee JE. Early precursors of site-specific cancers in college men and women. JNCI 1985; 74: 43–51.
Greenwald P, Damon A, Kirmss V, Polan AK. Physical and demographic features of men before developing cancer of the prostate. JNCI 1974; 53: 341–6.
Mantzoros CS, Georgiadis EI. Body mass and physical activity are important predictors of serum androgen concentrations in young health men. Epidemiology 1995; 6: 433–5.
Severson RK, Grove JS, Nomura AMY, et al. Body mass and prostatic cancer: a prospective study. Brit Med J 1988; 297: 713–5.
Henderson BE. Summary report of the Sixth Symposium on Cancer Registries and Epidemiology in the Pacific Basin. JNCI 1990; 82: 1186–90.
Nomura A, Heilbrun LK, Stemmermann GN, Judd HL. Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 1988; 48: 3515–7.
Hsing AW, Comstock GW. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomark Prev 1993; 2: 27–32.
Tibblin G, Eriksson M, Cnattingius S, Ekbom A. High birthweight as a predictor of prostate cancer risk. Epidemiology 1995; 6: 423–4.
Pollard M, Luckert PH. Promotional efects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 1986: 32: 223–7.
Kroes R, Beems RB, Bosland MC, Bunnik GSJ, Sinkeldam EJ. Nutritional factors in lung, colon, and prostate carcinogenesis in animal models. Federation Proc 1986; 45: 136–41.
Chaproniere DM, Webber MM. Dexamethasone and retinyl acetate similarly inhibit and stimulate EGF-or insulin-induced proliferation of prostatic epithelium. J Cell Physiol 1985; 122: 249–53.
Haddow A, Roe FJC, Dukes CE, Mitchley BCV. Cadmium neoplasia: Sarcomata at the site of injection of cadmium sulphate in rats and mice. Br J Cancer 1964; 18: 667–73.
Roe FJC, Dukes CE, Cameron KM, Pugh RCB, Mitchley BCV. Cadmium neoplasia: Testicular atrophy and Leydig cell hyperplasia and neoplasia in rats and mice following the subcutaneous injection of cadmium salts. Br J Cancer 1964; 18: 674–81.
Gunn SA, Gould TC, Anderson WAD. Specific response of mesenchymal tissue in cancerogenesis by cadmium. Arch Pathol 1967; 83: 493–9.
Gunn SA, Gould TC, Anderson WAD. Effects of zinc on cancerogenesis by cadmium. Proc Soc Exp Biol Med 1964; 115: 653–7.
Hankin JH, Zhao LP, Wilkens LR, Kolonel LN. Attributable risk of breast, prostate and lung cancer in Hawaii due to saturated fat. Cancer Causes Control 1992; 3: 17–23.
Author information
Authors and Affiliations
Additional information
This project is funded partially by the National Cancer Institute grant nos. P01 CA 33619 and R01 CA 54281 from the US National Institutes of Health.
Rights and permissions
About this article
Cite this article
Kolonel, L.N. Nutrition and prostate cancer. Cancer Causes Control 7, 83–94 (1996). https://doi.org/10.1007/BF00115640
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00115640